Hypochlorous Acid

Hypochlorous Acid

SCHEMBL3965623

Nc1ccc(-c2ccc(N)c(N)c2N)cc1.OCl.OCl.OCl.OCl

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.42
ALDH1A1 P00352 5/20 0.42
TDP1 Q9NUW8 3/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 5/20 0.36
TAAR1 Q96RJ0 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
ALOX15 P16050 3/20 0.33
APP P05067 2/20 0.33
THRB P10828 2/20 0.33
CASP1 P29466 2/20 0.33
PDK2 Q15119 1/20 0.33
CA3 P07451 1/20 0.33
CA6 P23280 1/20 0.33
HIF1A Q16665 1/20 0.33
CA14 Q9ULX7 1/20 0.33
TDP2 O95551 1/20 0.33
AURKA O14965 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL843774 0.93 CYP3A4 (0.43) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL21373 0.93 TDP1 (0.48) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL5983370 0.93 TDP1 (0.48) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL30272720 0.93 TDP1 (0.48) CYP3A4ALDH1A1TDP1TP53HSD17B10
Water SCHEMBL7066183 0.91 TDP1 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL992776 0.91 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL134929 0.91 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL3507048 0.91 TDP1 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL999548 0.91 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Ammonia Solution, Strong SCHEMBL27597352 0.91 TDP1 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023082193-A1 METHOD FOR MODULATING TUMOR MICROENVIRONMENT TOWARD ANTI-CANCER PHENOTYPE IN A SUBJECT IN NEED THEREOF USING NANO-MODULATOR AND APPLICATIONS THEREOF SHIEH, DAR-BIN (CN) 2023-05-19 WO disclosed
US-20140162950-A1 METHOD FOR INHIBITING PERITONEAL METASTASIS CAUSED BY GASTRIC CANCER CELLS NATIONAL TAIWAN UNIVERSITY (TW) 2014-06-12 US disclosed
US-20130052157-A1 USE OF IL-17E FOR CANCER TREATMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-02-28 US disclosed
EP-2081585-A2 CANCER TREATMENT The Regents of the University of California (US) 2009-07-29 EP disclosed
WO-2008067057-A2 CANCER TREATMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-06-05 WO disclosed